Followers

Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

No comments:

Post a Comment

Loan-related complaints up 43% in FY24, says RBI report

Consumer complaints related to loans and advances rose 43%, representing 29% of the total grievances against RBI-regulated entities in FY24,...